No apparent impact of incremental dosing on eliciting dose at double-blind, placebo-controlled peanut challenge
Author(s)
Turner, Paul
Durham, Stephen
Skypala, Isabel
Boyle, RB
Type
Journal Article
Date Issued
2022-02
Date Acceptance
2021-10-03
Citation
Allergy, 2022, 77 (2), pp.667-670
ISSN
0105-4538
Publisher
John Wiley and Sons
Start Page
667
End Page
670
Journal / Book Title
Allergy
Volume
77
Issue
2
Copyright Statement
© 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
License URL
Sponsor
Medical Research Council (MRC)
Commission of the European Communities
Identifier
https://onlinelibrary.wiley.com/doi/10.1111/all.15130
Grant Number
MR/K010468/1
312147
Subjects
Science & Technology
Life Sciences & Biomedicine
Allergy
Immunology
allergy
eliciting dose
food challenge
lowest observed adverse effect level
peanut
FOOD CHALLENGES
allergy
eliciting dose
food challenge
lowest observed adverse effect level
peanut
Allergy
1107 Immunology
Publication Status
Published
Date Publish Online
2021-10-06